Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Results of a Patient Survey Regarding COPD Knowledge, Treatment Experiences, and Practices With Inhalation Devices.

Dhand R, Mahler DA, Carlin B, Hanania N, Ohar J, Pinto-Plata V, Shah T, Eubanks D, Braman SS.

Respir Care. 2018 Mar 20. pii: respcare.05715. doi: 10.4187/respcare.05715. [Epub ahead of print]

PMID:
29559537
2.

Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort.

Divo MJ, Celli BR, Poblador-Plou B, Calderón-Larrañaga A, de-Torres JP, Gimeno-Feliu LA, Bertó J, Zulueta JJ, Casanova C, Pinto-Plata VM, Cabrera-Lopez C, Polverino F, Carmona Píréz J, Prados-Torres A, Marin JM; EpiChron—BODE Collaborative Group.

PLoS One. 2018 Feb 22;13(2):e0193143. doi: 10.1371/journal.pone.0193143. eCollection 2018.

3.

Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.

Celli BR, Locantore N, Tal-Singer R, Riley J, Miller B, Vestbo J, Yates JC, Silverman EK, Owen CA, Divo M, Pinto-Plata V, Wouters EFM, Faner R, Agusti A; ECLIPSE Study Investigators.

Eur Respir J. 2018 Feb 7;51(2). pii: 1702146. doi: 10.1183/13993003.02146-2017. Print 2018 Feb.

PMID:
29437944
4.

Human Lung DNA Methylation Quantitative Trait Loci Colocalize with COPD Genome-wide Association Loci.

Morrow JD, Glass K, Cho MH, Hersh CP, Pinto-Plata V, Celli B, Marchetti N, Criner G, Bueno R, Washko G, Choi AMK, Quackenbush J, Silverman EK, DeMeo DL.

Am J Respir Crit Care Med. 2018 Jan 9. doi: 10.1164/rccm.201707-1434OC. [Epub ahead of print]

PMID:
29313708
5.

Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.

Casanova C, Celli BR, de-Torres JP, Martínez-Gonzalez C, Cosio BG, Pinto-Plata V, de Lucas-Ramos P, Divo M, Fuster A, Peces-Barba G, Calle-Rubio M, Solanes I, Aguero R, Feu-Collado N, Alfageme I, De Diego A, Romero A, Balcells E, Llunell A, Galdiz JB, Marin M, Moreno A, Cabrera C, Golpe R, Lacarcel C, Soriano JB, López-Campos JL, Soler-Cataluña JJ, Marin JM.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701162. doi: 10.1183/13993003.01162-2017. Print 2017 Nov.

PMID:
29167301
6.

Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and Outcomes.

Cabrera López C, Casanova Macario C, Marín Trigo JM, de-Torres JP, Sicilia Torres R, González JM, Polverino F, Divo M, Pinto Plata V, Zulueta JJ, Celli B.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):463-469. doi: 10.1164/rccm.201707-1363OC.

PMID:
29099607
7.

Chronic Obstructive Pulmonary Disease in Elderly Patients.

Cortopassi F, Gurung P, Pinto-Plata V.

Clin Geriatr Med. 2017 Nov;33(4):539-552. doi: 10.1016/j.cger.2017.06.006. Epub 2017 Aug 23. Review.

PMID:
28991649
8.

Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients.

Zagaceta J, Bastarrika G, Zulueta JJ, Colina I, Alcaide AB, Campo A, Divo M, Casanova C, Marin JM, Pinto-Plata VM, Celli BR, de-Torres JP.

Respir Res. 2017 Sep 29;18(1):175. doi: 10.1186/s12931-017-0658-y.

9.

Functional interactors of three genome-wide association study genes are differentially expressed in severe chronic obstructive pulmonary disease lung tissue.

Morrow JD, Zhou X, Lao T, Jiang Z, DeMeo DL, Cho MH, Qiu W, Cloonan S, Pinto-Plata V, Celli B, Marchetti N, Criner GJ, Bueno R, Washko GR, Glass K, Quackenbush J, Choi AM, Silverman EK, Hersh CP.

Sci Rep. 2017 Mar 13;7:44232. doi: 10.1038/srep44232.

10.

A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.

Polverino F, Laucho-Contreras ME, Petersen H, Bijol V, Sholl LM, Choi ME, Divo M, Pinto-Plata V, Chetta A, Tesfaigzi Y, Celli BR, Owen CA.

Am J Respir Crit Care Med. 2017 Jun 1;195(11):1464-1476. doi: 10.1164/rccm.201609-1765OC.

PMID:
28085500
11.

Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study.

Andrianopoulos V, Celli BR, Franssen FM, Pinto-Plata VM, Calverley PM, Vanfleteren LE, Vogiatzis I, Vestbo J, Agusti A, Bakke PS, Rennard SI, MacNee W, Tal-Singer R, Yates JC, Wouters EF, Spruit MA.

Respir Med. 2016 Oct;119:87-95. doi: 10.1016/j.rmed.2016.08.023. Epub 2016 Aug 25.

PMID:
27692154
12.

DNA methylation profiling in human lung tissue identifies genes associated with COPD.

Morrow JD, Cho MH, Hersh CP, Pinto-Plata V, Celli B, Marchetti N, Criner G, Bueno R, Washko G, Glass K, Choi AM, Quackenbush J, Silverman EK, DeMeo DL.

Epigenetics. 2016 Aug 26:1-10. [Epub ahead of print]

13.

Is COPD a Progressive Disease? A Long Term Bode Cohort Observation.

de-Torres JP, Marín JM, Pinto-Plata V, Divo M, Sanchez-Salcedo P, Zagaceta J, Zulueta JJ, Berto J, Cabrera C, Celli BR, Casanova C.

PLoS One. 2016 Apr 21;11(4):e0151856. doi: 10.1371/journal.pone.0151856. eCollection 2016.

14.

Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?

Polverino F, Laucho-Contreras M, Rojas Quintero J, Divo M, Pinto-Plata V, Sholl L, de-Torres JP, Celli BR, Owen CA.

Multidiscip Respir Med. 2016 Apr 4;11:17. doi: 10.1186/s40248-016-0051-6. eCollection 2016.

15.

Simplifying the guidelines: The 10 COPD commandments.

Marin JM, Cote C, Casanova C, Pinto-Plata V, Montes de Oca M, Divo MJ, de Torres JP, Zulueta J, Cabrera C, Carrizo S, Polverino F, Celli BR; En Representación del Grupo BODE.

Arch Bronconeumol. 2016 Apr;52(4):179-80. doi: 10.1016/j.arbres.2016.01.012. Epub 2016 Mar 10. English, Spanish. No abstract available.

16.

Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease.

Hobbs BD, Parker MM, Chen H, Lao T, Hardin M, Qiao D, Hawrylkiewicz I, Sliwinski P, Yim JJ, Kim WJ, Kim DK, Castaldi PJ, Hersh CP, Morrow J, Celli BR, Pinto-Plata VM, Criner GJ, Marchetti N, Bueno R, Agustí A, Make BJ, Crapo JD, Calverley PM, Donner CF, Lomas DA, Wouters EF, Vestbo J, Paré PD, Levy RD, Rennard SI, Zhou X, Laird NM, Lin X, Beaty TH, Silverman EK, Cho MH; NETT Genetics Investigators; ECLIPSE Investigators; COPDGene Investigators; International COPD Genetics Network Investigators.

Am J Respir Crit Care Med. 2016 Jul 1;194(1):48-57. doi: 10.1164/rccm.201510-2053OC.

17.

Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease.

Qiao D, Lange C, Beaty TH, Crapo JD, Barnes KC, Bamshad M, Hersh CP, Morrow J, Pinto-Plata VM, Marchetti N, Bueno R, Celli BR, Criner GJ, Silverman EK, Cho MH; Lung GO; NHLBI Exome Sequencing Project; COPDGene Investigators.

Am J Respir Crit Care Med. 2016 Jun 15;193(12):1353-63. doi: 10.1164/rccm.201506-1223OC.

18.

Handgrip weakness and mortality risk in COPD: a multicentre analysis.

Burtin C, Ter Riet G, Puhan MA, Waschki B, Garcia-Aymerich J, Pinto-Plata V, Celli B, Watz H, Spruit MA.

Thorax. 2016 Jan;71(1):86-7. doi: 10.1136/thoraxjnl-2015-207451. Epub 2015 Oct 29. No abstract available.

PMID:
26514408
19.

Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.

de-Torres JP, Marín JM, Casanova C, Pinto-Plata V, Divo M, Cote C, Celli BR, Zulueta JJ.

Chest. 2016 Apr;149(4):936-42. doi: 10.1378/chest.15-1868. Epub 2016 Jan 12.

PMID:
26513409
20.

Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease.

Kohli P, Pinto-Plata V, Divo M, Malhotra A, Harris RS, Lazaar A, Flynn A, Tal-Singer R, Panettieri RA Jr, Celli B.

J Cardiopulm Rehabil Prev. 2015 Sep-Oct;35(5):348-55. doi: 10.1097/HCR.0000000000000123.

21.

COPD comorbidities network.

Divo MJ, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta JJ, Cabrera C, Zagaceta J, Sanchez-Salcedo P, Berto J, Davila RB, Alcaide AB, Cote C, Celli BR; BODE Collaborative Group.

Eur Respir J. 2015 Sep;46(3):640-50. doi: 10.1183/09031936.00171614. Epub 2015 Jul 9.

22.

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.

Lange P, Celli B, Agustí A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, Meek P, Owen CA, Petersen H, Pinto-Plata V, Schnohr P, Sood A, Soriano JB, Tesfaigzi Y, Vestbo J.

N Engl J Med. 2015 Jul 9;373(2):111-22. doi: 10.1056/NEJMoa1411532.

23.

Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study.

Andrianopoulos V, Wouters EF, Pinto-Plata VM, Vanfleteren LE, Bakke PS, Franssen FM, Agusti A, MacNee W, Rennard SI, Tal-Singer R, Vogiatzis I, Vestbo J, Celli BR, Spruit MA.

Respir Med. 2015 Sep;109(9):1138-46. doi: 10.1016/j.rmed.2015.06.013. Epub 2015 Jun 25.

24.

B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.

Polverino F, Cosio BG, Pons J, Laucho-Contreras M, Tejera P, Iglesias A, Rios A, Jahn A, Sauleda J, Divo M, Pinto-Plata V, Sholl L, Rosas IO, Agustí A, Celli BR, Owen CA.

Am J Respir Crit Care Med. 2015 Sep 15;192(6):695-705. doi: 10.1164/rccm.201501-0107OC.

25.

Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD.

Díaz AA, Pinto-Plata V, Hernández C, Peña J, Ramos C, Díaz JC, Klaassen J, Patino CM, Saldías F, Díaz O.

Respir Med. 2015 Jul;109(7):882-9. doi: 10.1016/j.rmed.2015.04.009. Epub 2015 Apr 23.

26.

A randomised trial of lung sealant versus medical therapy for advanced emphysema.

Come CE, Kramer MR, Dransfield MT, Abu-Hijleh M, Berkowitz D, Bezzi M, Bhatt SP, Boyd MB, Cases E, Chen AC, Cooper CB, Flandes J, Gildea T, Gotfried M, Hogarth DK, Kolandaivelu K, Leeds W, Liesching T, Marchetti N, Marquette C, Mularski RA, Pinto-Plata VM, Pritchett MA, Rafeq S, Rubio ER, Slebos DJ, Stratakos G, Sy A, Tsai LW, Wahidi M, Walsh J, Wells JM, Whitten PE, Yusen R, Zulueta JJ, Criner GJ, Washko GR.

Eur Respir J. 2015 Sep;46(3):651-62. doi: 10.1183/09031936.00205614. Epub 2015 Apr 2.

27.

Protective role for club cell secretory protein-16 (CC16) in the development of COPD.

Laucho-Contreras ME, Polverino F, Gupta K, Taylor KL, Kelly E, Pinto-Plata V, Divo M, Ashfaq N, Petersen H, Stripp B, Pilon AL, Tesfaigzi Y, Celli BR, Owen CA.

Eur Respir J. 2015 Jun;45(6):1544-56. doi: 10.1183/09031936.00134214. Epub 2015 Feb 19.

28.

A novel nonhuman primate model of cigarette smoke-induced airway disease.

Polverino F, Doyle-Eisele M, McDonald J, Wilder JA, Royer C, Laucho-Contreras M, Kelly EM, Divo M, Pinto-Plata V, Mauderly J, Celli BR, Tesfaigzi Y, Owen CA.

Am J Pathol. 2015 Mar;185(3):741-55. doi: 10.1016/j.ajpath.2014.11.006. Epub 2014 Dec 24.

29.

Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index.

Divo MJ, Cabrera C, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta J, Zagaceta J, Sanchez-Salcedo P, Berto J, Cote C, Celli BR.

Chronic Obstr Pulm Dis. 2014 Sep 25;1(2):229-238. doi: 10.15326/jcopdf.1.2.2014.0117.

30.

Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE.

de Torres JP, Casanova C, Marín JM, Pinto-Plata V, Divo M, Zulueta JJ, Berto J, Zagaceta J, Sanchez-Salcedo P, Cabrera C, Carrizo S, Cote C, Celli BR.

Thorax. 2014 Sep;69(9):799-804. doi: 10.1136/thoraxjnl-2014-205770. Epub 2014 Jun 26.

PMID:
24969641
31.

Mononuclear phagocytes and airway epithelial cells: novel sources of matrix metalloproteinase-8 (MMP-8) in patients with idiopathic pulmonary fibrosis.

Craig VJ, Polverino F, Laucho-Contreras ME, Shi Y, Liu Y, Osorio JC, Tesfaigzi Y, Pinto-Plata V, Gochuico BR, Rosas IO, Owen CA.

PLoS One. 2014 May 14;9(5):e97485. doi: 10.1371/journal.pone.0097485. eCollection 2014.

32.

Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.

Sanchez-Salcedo P, Divo M, Casanova C, Pinto-Plata V, de-Torres JP, Cote C, Cabrera C, Zagaceta J, Rodriguez-Roisin R, Zulueta JJ, Marin JM, Celli B.

Eur Respir J. 2014 Aug;44(2):324-31. doi: 10.1183/09031936.00208613. Epub 2014 Apr 2.

33.

Comparison of arterial and venous blood biomarker levels in chronic obstructive pulmonary disease.

Kelly E, Owen CA, Abraham A, Knowlton DL, Celli BR, Pinto-Plata V.

F1000Res. 2013 Apr 19;2:114. doi: 10.12688/f1000research.2-114.v1. eCollection 2013.

34.

Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Gazourian L, Rogers AJ, Ibanga R, Weinhouse GL, Pinto-Plata V, Ritz J, Soiffer RJ, Antin JH, Washko GR, Baron RM, Ho VT.

Am J Hematol. 2014 Apr;89(4):404-9. doi: 10.1002/ajh.23656. Epub 2014 Feb 21.

35.

Obstructive lung disease in Mexican Americans and non-Hispanic whites: an analysis of diagnosis and survival in the National Health and Nutritional Examination Survey III Follow-up Study.

Diaz AA, Come CE, Mannino DM, Pinto-Plata V, Divo MJ, Bigelow C, Celli B, Washko GR.

Chest. 2014 Feb;145(2):282-289. doi: 10.1378/chest.13-1414.

36.

Longitudinal assessment in COPD patients: multidimensional variability and outcomes.

Casanova C, Aguirre-Jaíme A, de Torres JP, Pinto-Plata V, Baz R, Marin JM, Divo M, Cordoba E, Basaldua S, Cote C, Celli BR.

Eur Respir J. 2014 Mar;43(3):745-53. doi: 10.1183/09031936.00096913. Epub 2013 Sep 26.

37.

Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use.

Petersen H, Sood A, Meek PM, Shen X, Cheng Y, Belinsky SA, Owen CA, Washko G, Pinto-Plata V, Kelly E, Celli B, Tesfaigzi Y.

Chest. 2014 Apr;145(4):695-703. doi: 10.1378/chest.13-0799.

38.

The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease.

Kelly E, Owen CA, Pinto-Plata V, Celli BR.

Expert Rev Respir Med. 2013 Feb;7(1):57-64. doi: 10.1586/ers.12.82.

PMID:
23362815
39.

Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.

Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agustí A, Bakke PS, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Miller BE, Crim C, Yates J, Wouters EF, Celli B; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators.

Am J Respir Crit Care Med. 2013 Feb 15;187(4):382-6. doi: 10.1164/rccm.201209-1596OC. Epub 2012 Dec 21.

PMID:
23262518
40.

The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases.

Doyle TJ, Pinto-Plata V, Morse D, Celli BR, Rosas IO.

Chest. 2012 Oct;142(4):1027-1034. doi: 10.1378/chest.12-1540. Review.

41.

Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD.

Pinto-Plata V, Casanova C, Müllerova H, de Torres JP, Corado H, Varo N, Cordoba E, Zeineldine S, Paz H, Baz R, Divo M, Cortopassi F, Celli BR.

Respir Res. 2012 Aug 20;13:71. doi: 10.1186/1465-9921-13-71.

42.

Role of exercise in testing and in therapy of COPD.

Divo M, Pinto-Plata V.

Med Clin North Am. 2012 Jul;96(4):753-66. doi: 10.1016/j.mcna.2012.05.004. Review.

PMID:
22793943
43.

Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.

Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B; BODE Collaborative Group.

Am J Respir Crit Care Med. 2012 Jul 15;186(2):155-61. doi: 10.1164/rccm.201201-0034OC. Epub 2012 May 3.

PMID:
22561964
44.

The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.

Casanova C, de Torres JP, Aguirre-Jaíme A, Pinto-Plata V, Marin JM, Cordoba E, Baz R, Cote C, Celli BR.

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1015-21. doi: 10.1164/rccm.201105-0831OC.

PMID:
21836135
45.

Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease.

Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agusti A, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Crim CC, Yates J, Wouters EF; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators.

J Am Med Dir Assoc. 2012 Mar;13(3):291-7. doi: 10.1016/j.jamda.2011.06.009. Epub 2011 Jul 21.

PMID:
21778120
46.

Six-minute walking distance in women with COPD.

de Torres JP, Casanova C, Cote CG, López MV, Díaz O, María Marin J, Pinto-Plata V, Montes de Oca M, Aguirre-Jaime A, Celli BR.

COPD. 2011 Aug;8(4):300-5. doi: 10.3109/15412555.2011.589870. Epub 2011 Jul 18.

PMID:
21767075
47.

Prognostic assessment in COPD: health related quality of life and the BODE index.

Marin JM, Cote CG, Diaz O, Lisboa C, Casanova C, Lopez MV, Carrizo SJ, Pinto-Plata V, Dordelly LJ, Nekach H, Celli BR.

Respir Med. 2011 Jun;105(6):916-21. doi: 10.1016/j.rmed.2011.01.007. Epub 2011 Feb 1.

48.

Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study.

de Torres JP, Casanova C, Pinto-Plata V, Varo N, Restituto P, Cordoba-Lanus E, Baz-Dávila R, Aguirre-Jaime A, Celli BR.

PLoS One. 2011 Jan 18;6(1):e16021. doi: 10.1371/journal.pone.0016021.

49.

Resting handgrip force and impaired cardiac function at rest and during exercise in COPD patients.

Cortopassi F, Divo M, Pinto-Plata V, Celli B.

Respir Med. 2011 May;105(5):748-54. doi: 10.1016/j.rmed.2010.12.011. Epub 2011 Jan 19.

50.

The 6-min walk distance in healthy subjects: reference standards from seven countries.

Casanova C, Celli BR, Barria P, Casas A, Cote C, de Torres JP, Jardim J, Lopez MV, Marin JM, Montes de Oca M, Pinto-Plata V, Aguirre-Jaime A; Six Minute Walk Distance Project (ALAT).

Eur Respir J. 2011 Jan;37(1):150-6. doi: 10.1183/09031936.00194909. Epub 2010 Jun 4.

Supplemental Content

Loading ...
Support Center